108 related articles for article (PubMed ID: 7110144)
1. Effect of monoclonal anti-neuraminidase antibodies on the kinetic behavior of influenza virus neuraminidase.
Mountford CE; Grossman G; Holmes KT; O'Sullivan WJ; Hampson AW; Raison RL; Webster R
Mol Immunol; 1982 Jun; 19(6):811-6. PubMed ID: 7110144
[TBL] [Abstract][Full Text] [Related]
2. Antigenic and biological characterization of influenza virus neuraminidase (N2) with monoclonal antibodies.
Webster RG; Brown LE; Laver WG
Virology; 1984 May; 135(1):30-42. PubMed ID: 6203218
[TBL] [Abstract][Full Text] [Related]
3. Anti-neuraminidase antibodies: which substrate should be used to test their effect on influenza virus neuraminidase.
Mountford CE; Holmes KT; Hampson AW
Biochem Biophys Res Commun; 1981 Nov; 103(2):469-74. PubMed ID: 6977358
[No Abstract] [Full Text] [Related]
4. Catalytic properties of the A/H3N2 influenza neuraminidases: influence of antigenic variations.
Deshairs C; Kessler N; Aymard M; Quash GA
J Gen Virol; 1986 Mar; 67 ( Pt 3)():409-18. PubMed ID: 3950578
[TBL] [Abstract][Full Text] [Related]
5. A comparison of two anti-neuraminidase monoclonal antibodies by complement activation.
Holmes KT; Hampson AW; Raison RL; Webster RG; O'Sullivan WJ; Mountford CE
Eur J Immunol; 1982 Jun; 12(6):523-6. PubMed ID: 7117362
[TBL] [Abstract][Full Text] [Related]
6. A topographic map of the enzyme active center and antigenic sites on the neuraminidase of influenza virus A/Tokyo/3/67 (H2N2).
Jackson DC; Webster RG
Virology; 1982 Nov; 123(1):69-77. PubMed ID: 6183827
[No Abstract] [Full Text] [Related]
7. Analysis of the binding of the Fab fragment of monoclonal antibody NC10 to influenza virus N9 neuraminidase from tern and whale using the BIAcore biosensor: effect of immobilization level and flow rate on kinetic analysis.
Kortt AA; Nice E; Gruen LC
Anal Biochem; 1999 Aug; 273(1):133-41. PubMed ID: 10452809
[TBL] [Abstract][Full Text] [Related]
8. The equilibrium constant for the interaction between a monoclonal Fab fragment and an influenza virus neuraminidase.
Jackson DC; Howlett GJ; Nestorowicz A; Webster RG
J Immunol; 1983 Mar; 130(3):1313-6. PubMed ID: 6822736
[TBL] [Abstract][Full Text] [Related]
9. Crystalline monoclonal fab fragment with specificity towards an influenza virus neuraminidase.
Colman PM; Gough KH; Lilley GG; Blagrove RJ; Webster RG; Laver WG
J Mol Biol; 1981 Nov; 152(3):609-14. PubMed ID: 7328664
[No Abstract] [Full Text] [Related]
10. Neuraminidase-inhibition assay for the identification of influenza A virus neuraminidase subtype or neuraminidase antibody specificity.
Pedersen JC
Methods Mol Biol; 2008; 436():67-75. PubMed ID: 18370042
[TBL] [Abstract][Full Text] [Related]
11. Location of antigenic sites on the three-dimensional structure of the influenza N2 virus neuraminidase.
Air GM; Els MC; Brown LE; Laver WG; Webster RG
Virology; 1985 Sep; 145(2):237-48. PubMed ID: 2411049
[TBL] [Abstract][Full Text] [Related]
12. Analysis of influenza A virus neuraminidase using lectin test and monoclonal antibodies.
Varecková E; Lyubovtseva OV; Russ G; Styk B; Zakstelskaya LYa ; Yakhno MA
Acta Virol; 1986 Jul; 30(4):281-8. PubMed ID: 2876609
[TBL] [Abstract][Full Text] [Related]
13. The complete neuraminidase of influenza A/PR8/34 (H0N1) is not detectable in its recombinant virus.
Arora DJ; Hill-Schubert J
Can J Microbiol; 1980 Nov; 26(11):1369-73. PubMed ID: 7214226
[TBL] [Abstract][Full Text] [Related]
14. Qualitative and quantitative analyses of virtually all subtypes of influenza A and B viral neuraminidases using antibodies targeting the universally conserved sequences.
Gravel C; Li C; Wang J; Hashem AM; Jaentschke B; Xu KW; Lorbetskie B; Gingras G; Aubin Y; Van Domselaar G; Girard M; He R; Li X
Vaccine; 2010 Aug; 28(36):5774-84. PubMed ID: 20621113
[TBL] [Abstract][Full Text] [Related]
15. [Antigenic specificity of the neuraminidases of epidemic strains of influenza A/H3N2 viruses circulating in the USSR 1983-1985].
Liubovtseva OV; Iakhno MA; Zakstel'skaia LIa
Vopr Virusol; 1987; 32(3):283-5. PubMed ID: 2445104
[TBL] [Abstract][Full Text] [Related]
16. Antigenic structure and variation in an influenza virus N9 neuraminidase.
Webster RG; Air GM; Metzger DW; Colman PM; Varghese JN; Baker AT; Laver WG
J Virol; 1987 Sep; 61(9):2910-6. PubMed ID: 3612957
[TBL] [Abstract][Full Text] [Related]
17. Selection and analysis of antigenic variants of the neuraminidase of N2 influenza viruses with monoclonal antibodies.
Webster RG; Hinshaw VS; Laver WG
Virology; 1982 Feb; 117(1):93-104. PubMed ID: 7064355
[No Abstract] [Full Text] [Related]
18. Influenza virus neuraminidase with hemagglutinin activity.
Laver WG; Colman PM; Webster RG; Hinshaw VS; Air GM
Virology; 1984 Sep; 137(2):314-23. PubMed ID: 6485252
[TBL] [Abstract][Full Text] [Related]
19. Neuraminidase-inhibition assay for the identification of influenza A virus neuraminidase virus subtype or neuraminidase antibody specificity.
Pedersen JC
Methods Mol Biol; 2014; 1161():27-36. PubMed ID: 24899417
[TBL] [Abstract][Full Text] [Related]
20. Contribution to the standardization of influenza neuraminidase inhibition tests, based on enzyme- antienzyme kinetic studies.
Siekmann U; Schoop HJ; Kuwert E
Dev Biol Stand; 1975; 28():324-35. PubMed ID: 1126576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
